In a report released today, Shaul Eyal from TD Cowen reiterated a Buy rating on Cellebrite DI, with a price target of $25.00. The company’s shares opened today at $19.20.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Eyal covers the Technology sector, focusing on stocks such as Fortinet, Palo Alto Networks, and Okta. According to TipRanks, Eyal has an average return of 27.0% and a 70.54% success rate on recommended stocks.
Cellebrite DI has an analyst consensus of Strong Buy, with a price target consensus of $21.29, which is a 10.89% upside from current levels. In a report released today, Lake Street also reiterated a Buy rating on the stock with a $22.00 price target.
CLBT market cap is currently $4.43B and has a P/E ratio of -24.78.
Read More on CLBT:
Disclaimer & DisclosureReport an Issue
- Cellebrite price target raised to $23 from $20 at JPMorgan
- Cellebrite DI Shareholders Approve Proposals at Annual Meeting
- Cellebrite DI’s Strategic Growth and Market Expansion: Analyst Recommends Buy Rating
- Cellebrite’s Earnings Call: Growth Amid Challenges
- Cellebrite participates in a conference call with Craig-Hallum
/Super%20Micro%20Computer%20Inc%20logo%20on%20building-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Microsoft%20Corporation%20logo%20on%20sign-by%20Jean-Luc%20Ichard%20via%20iStock.jpg)